01 January 1970 7 9K Report

Methicillin-resistant Staphylococcus aureus (MRSA) ESBL-producing Enterobacteriaceae (extended-spectrum β-lactamases) Vancomycin-resistant Enterococcus (VRE) Multidrug-resistant Pseudomonas aeruginosa.

we have done a research on the effectiveness of sliver nanoparticle on MRSA.

do you have any recommendations on what is the best route to take I would love to hear your opinio.

Similar questions and discussions